Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for inflammatory markers in β-thalassemia
IRCT2015101411819N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in beta thalassemia, sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Inflammatory markers change. Started Dec 2014; status: completed.
02
Drugs
silymarin
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on IRCT2015101411819N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015101411819N3.